Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

A computer screen shows the user interface of mint Lesion™  on which the analytical evaluation of a scan can be seen

Brainlab and Mint Medical Enter Cooperation with the German Society for Orthopedics and Orthopedic Surgery

Today Mint Medical together with Brainlab entered into a cooperation with the German Society for Orthopedics and Orthopedic Surgery (DGOOC) and its non-profit subsidiary, RSG Register Solutions to develop a data protection-compliant registry infrastructure for patient data processing and thus strengthen medical research across healthcare institutions.

Mint Medical’s software is already being used in all 38 German university hospitals as part of the University Medicine Network RACOON project to record and categorize medical imaging and other data from Covid patients. Through the partnership with RSG, Mint Medical can now expand its registry offering and securely correlate patient data across hospitals and throughout patient treatment while maintaining strict data protection criteria.

Click here to read the full press release.

Related Resources

Related Resources

Several juxtaposed images of different patients with different responses to the cancer treatment

Study with mint Lesion™ compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study conducted by researchers at University Hospital Tuebingen retrospectively compared two liver-targeted therapies for uveal melanoma patients…

RECIST measurements of a patient with uveal melanoma and hepatic metastases

University Hospital Tuebingen: Study compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study[1] conducted by researchers at University Hospital Tuebingen retrospectively compared the efficacy of two liver-targeted therapies,…

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…